These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17888597)

  • 1. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole.
    Jung H; Kim HM; Choy YB; Hwang SJ; Choy JH
    Int J Pharm; 2008 Feb; 349(1-2):283-90. PubMed ID: 17888597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
    Tao T; Zhao Y; Wu J; Zhou B
    Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of donepezil intercalated in smectite clays.
    Park JK; Choy YB; Oh JM; Kim JY; Hwang SJ; Choy JH
    Int J Pharm; 2008 Jul; 359(1-2):198-204. PubMed ID: 18502063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method.
    Li XS; Wang JX; Shen ZG; Zhang PY; Chen JF; Yun J
    Int J Pharm; 2007 Sep; 342(1-2):26-32. PubMed ID: 17566675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of stabilized itraconazole nanodispersions by using high-gravity technique.
    Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
    Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
    Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
    Shelke NB; Aminabhavi TM
    Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles.
    Takahashi T; Yamada Y; Kataoka K; Nagasaki Y
    J Control Release; 2005 Oct; 107(3):408-16. PubMed ID: 16171884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
    Janssens S; de Armas HN; Remon JP; Van den Mooter G
    Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide.
    Al-Marzouqi AH; Shehatta I; Jobe B; Dowaidar A
    J Pharm Sci; 2006 Feb; 95(2):292-304. PubMed ID: 16372306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles.
    Sairam M; Babu VR; Vijaya B; Naidu K; Aminabhavi TM
    Int J Pharm; 2006 Aug; 320(1-2):131-6. PubMed ID: 16766148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion.
    Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van Den Mooter G
    Eur J Pharm Sci; 2008 Nov; 35(4):344-53. PubMed ID: 18765282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
    Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
    Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.
    Matteucci ME; Paguio JC; Miller MA; Williams RO; Johnston KP
    Mol Pharm; 2009; 6(2):375-85. PubMed ID: 19236040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.